Related references
Note: Only part of the references are listed.circOMA1-Mediated miR-145-5p Suppresses Tumor Growth of Nonfunctioning Pituitary Adenomas by Targeting TPT1
Qiu Du et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
CXCL12-regulated miR-370-3p functions as a tumor suppressor gene by targeting HMGA2 in nonfunctional pituitary adenomas
Feng Cai et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2019)
European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas
Gerald Raverot et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2018)
VEGF as a modulator of the innate immune response in glioblastoma
Kati Turkowski et al.
GLIA (2018)
Complete evaluation of pituitary tumours in a single tertiary care institution
Dimitrios Askitis et al.
ENDOCRINE (2018)
From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal
S. L. Asa et al.
ENDOCRINE-RELATED CANCER (2017)
MANAGEMENT OF ENDOCRINE DISEASE Present and future perspectives for medical therapy of nonfunctioning pituitary adenomas
Yona Greenman
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2017)
The impact of transsphenoidal surgery on neurocognitive function: A systematic review
Adnan Alsumali et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2017)
25-Hydroxycholesterol promotes migration and invasion of lung adenocarcinoma cells
Li Chen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Silent subtype 3 pituitary adenomas are not always silent and represent poorly differentiated monomorphous plurihormonal Pit-1 lineage adenomas
Ozgur Mete et al.
MODERN PATHOLOGY (2016)
Optimal management of non-functioning pituitary adenomas
Yona Greenman et al.
ENDOCRINE (2015)
Emerging Targets in Pituitary Adenomas: Role of the CXCL12/CXCR4-R7 System
Federica Barbieri et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2014)
Non-functioning pituitary tumors: 2012 update
Rosa Camara Gomez
ENDOCRINOLOGIA Y NUTRICION (2014)
VEGFA and tumour angiogenesis
L. Claesson-Welsh et al.
JOURNAL OF INTERNAL MEDICINE (2013)
Study on the Expression Levels of CXCR4, CXCL12, CD44, and CD147 and Their Potential Correlation with Invasive Behaviors of Pituitary Adenomas
Xing Bing et al.
BIOMEDICAL AND ENVIRONMENTAL SCIENCES (2013)
MicroRNA miR-107 is overexpressed in pituitary adenomas and inhibits the expression of aryl hydrocarbon receptor-interacting protein in vitro
Giampaolo Trivellin et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2012)
Anti-VEGF therapy in pituitary carcinoma
Leon D. Ortiz et al.
PITUITARY (2012)
Silencing of the Imprinted DLK1-MEG3 Locus in Human Clinically Nonfunctioning Pituitary Adenomas
Pornsuk Cheunsuchon et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
The Cyclic Pentapeptide d-Arg3FC131, a CXCR4 Antagonist, Induces Apoptosis of Somatotrope Tumor and Inhibits Tumor Growth in Nude Mice
Jeong Mo Kim et al.
ENDOCRINOLOGY (2011)
Autocrine VEGF Signaling Synergizes with EGFR in Tumor Cells to Promote Epithelial Cancer Development
Beate M. Lichtenberger et al.
CELL (2010)
CXCL12 (SDF-1)/CXCR4 Pathway in Cancer
Beverly A. Teicher et al.
CLINICAL CANCER RESEARCH (2010)
Absence of activating mutations of CXCR4 in pituitary tumours
Yong-ho Lee et al.
CLINICAL ENDOCRINOLOGY (2010)
Non-functioning pituitary adenomas
Yona Greenman et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Targeting the leukemia microenvironment by CXCR4 inhibition overcomes resistance to kinase inhibitors and chemotherapy in AML
Zhihong Zeng et al.
BLOOD (2009)
Signalling Pathway Alterations in Pituitary Adenomas: Involvement of Gsα, cAMP and Mitogen-Activated Protein Kinases
M. Pertuit et al.
JOURNAL OF NEUROENDOCRINOLOGY (2009)
Non-coding RNAs in imprinted gene clusters
Helene Royo et al.
BIOLOGY OF THE CELL (2008)
Overexpression of stromal cell-derived factor 1 and its receptor CXCR4 induces autocrine/paracrine cell proliferation in human pituitary adenomas
Federica Barbieri et al.
CLINICAL CANCER RESEARCH (2008)
Intracellular mediators of CXCR4-dependent signaling in T cells
Laura Patrussi et al.
IMMUNOLOGY LETTERS (2008)
Selective loss of MEG3 expression and intergenic differentially methylated region hypermethylation in the MEG3/DLK1 locus in human clinically nonfunctioning pituitary adenomas
Roger Gejman et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
CXCR4/CXCL12 axis promotes VEGF-mediated tumor angiogenesis through Akt signaling pathway
Zhongxing Liang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Tumor stromal-derived factor-1 recruits vascular progenitors to mitotic neovasculature, where microenvironment influences their differentiated phenotypes
Manish Aghi et al.
CANCER RESEARCH (2006)
SDF-1 and CXCR4 are up-regulated by VEGF and contribute to glioma cell invasion
Xin Hong et al.
CANCER LETTERS (2006)
Asymmetric regulation of imprinting on the maternal and paternal chromosomes at the Dlk1-Gtl2 imprinted cluster on mouse chromosome 12
SP Lin et al.
NATURE GENETICS (2003)
A pituitary-derived MEG3 isoform functions as a growth suppressor in tumor cells
X Zhang et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Epithelial-mesenchymal transitions in tumour progression
JP Thiery
NATURE REVIEWS CANCER (2002)
The snail superfamily of zinc-finger transcription factors
MA Nieto
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2002)
Share Paper
